课题基金 / 基金详情

Specific Imaging and Intracellular Hyperthermia for Brain Tumor using Magnetite Particle conjugated with monoclonal antibody

Specific Imaging and Intracellular Hyperthermia for Brain Tumor using Magnetite Particle conjugated with monoclonal antibody
使用与单克隆抗体结合的磁铁矿颗粒对脑肿瘤进行特异性成像和细胞内热疗
批准号:
08671574
负责人:
WAKABAYASHI Toshihiko
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

WAKABAYASHI Toshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, it was demonstrated that magnetite particle coupled to G-22 monoclonal antibody, could be useful for brain tumor imaging on MRI.After injection of this magnetite, tumor bearing mice were exposed to the magnetic field of an MRI scanner and T2 WI intensity in the tumor was compared with reference number. Result indicated a significant decreace of T2 WI intensity ratio in the tumor, suggesting specific accumulation of magnetite in the tumor. To the next study, we have investigated the possibility of hyperthermia for the tumor using this taregt directed magnetite in the high frequent magnetic field. When 375 Oe of magnetic field and 120kHz of frequency were applied, the magnetite in the tumor tissue were stimulated to be enough for heating tumor tissue to induce necrosis. These result suggest that target directed magnetite is expected to be not only for tumor enhancement agent in MRI, but also for the treatment strategy by hyperthermia for the tumor in the high frequent magnetic field.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Yanase M. et al.: "Intracellular Hyperthmia for Cancer using Megnetite Cationic Liposomes : An in two study" Jpn.J.Cancer Res.89. 463-469 (1998)
Yanase M. 等人:“使用磁铁矿阳离子脂质体治疗癌症的细胞内高温:两项研究”Jpn.J.Cancer Res.89。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yanase M. et al.: "Antitemor lmmity Induction by Intracllular Hyperthermin using Nagnetite Cationic Liposomes" Jpn.J.Cancer Res.89. 775-782 (1998)
Yanase M. 等人:“使用 Nagnetite 阳离子脂质体通过细胞内 Hyperthermin 诱导抗炎免疫”Jpn.J.Cancer Res.89。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masashige Shinkai, et al: "Development of novel magnetite sensing for brain lision using functional magnetic particles" KAGAKUKOUGAKU RONNBUNNSHI. Vol 24(2). 174-178 (1998)
Masashige Shinkai 等人:“利用功能性磁性粒子开发用于脑损伤的新型磁铁矿传感”KAGAKUKOUGAKU RONBUNNSHI。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yanase M, et al.: "Intracellular Hyperthermia for Cancrusing Magnetite Cationic Liposomes.Exvivostudy" Jpn.J.Caneer Res.88. 630-632 (1997)
Yanase M 等人:“用于癌症磁铁矿阳离子脂质体的细胞内热疗。Exvivostudy”Jpn.J.Caneer Res.88。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Development of molecular imaging tracers for anticancer drug resistant proteins
    • 批准号:
      21390409
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.57万
    • 财政年份:
      2009
    • 负责人:
      WAKABAYASHI Toshihiko
    • 依托单位:
    Clinical evaluation of efficacy and safety of dendritic cell-based vaccine therapy using with HLA-A2 restricted IL-13 alpha receptor peptide in patients with malignant glioma managed by international organization for standardization
    • 批准号:
      18390395
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2006
    • 负责人:
      WAKABAYASHI Toshihiko
    • 依托单位:
    Effective induction of antiglioma cytotoxic T cells by coadministration of heat-induction antigen by means of bio-nanoparticles dendritic cells
    • 批准号:
      16390409
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2004
    • 负责人:
      WAKABAYASHI Toshihiko
    • 依托单位:
    Induction of anti-tumor immunity by intracellular hyperthermia using magnetite
    • 批准号:
      14370430
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2002
    • 负责人:
      WAKABAYASHI Toshihiko
    • 依托单位:
    国内基金
    海外基金
    双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
    • 批准号:
      81271563
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2012
    • 负责人:
      陈正光
    • 依托单位: